E-Rx Innovation Hits Nation's Capital...

Published Online: Thursday, March 1, 2007

Washington, DC, has taken a major step in the electronic prescribing (e-prescribing) initiative. A Washington-based physician sent the first electronic prescription to a local Rite Aid pharmacy on January 17, according to SureScripts, operators of the Pharmacy Health Information Exchange.

The transmission followed the adoption in December 2006 by the Washington, DC, Board of Pharmacy of new rules making e-prescribing legal. The transmission also came on the heels of a new initiative by health plan payers, physician groups, and technology vendors to extend free e-prescribing to every physician in the United States.

Phil Keough, senior vice president of pharmacy operations for Rite Aid, favors e-prescribing. "Utilizing e-prescribing is a huge benefit for our patients, our pharmacists, and our physician partners. E-prescribing improves accuracy, eliminates unnecessary phone calls and faxes to physicians, and, most importantly, allows our pharmacists to spend more time counseling their patients, answering their questions, and ensuring their compliance with medication therapy."

SureScripts predicts that e-prescribing will be legal and live throughout the country during the first half of this year. The group is working closely with community pharmacies throughout Washington, DC, to immediately activate previously certified computer systems for e-prescribing. SureScripts has certified the software solutions being used by >95% of the nation's retail pharmacies. A majority of the Washington, DC, area's 113 retail pharmacies can now begin e-prescribing.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues